undamentalytics Newsletter

Congress: members

E. Scott Rigell

Backtest from 17 Jun 2015 to 2 Nov 2026 · weekly · hypothetical

Watch this strategy
Return a year
+12.3%
S&P 500 +13.8%
Last 12 months
+22.6%
S&P 500 +12.1%
Sharpe ratio
0.69
S&P 500 0.72
Biggest drop
−27.7%
S&P 500 −31.8%
$10.0k$20.0k$40.0k 201520172019202120232025 $43.4k$37.4k
E. Scott RigellS&P 500 $10,000 in E. Scott Rigell from 17 Jun 2015 against the S&P 500 (total return) over the same dates, marked weekly, log scale. Hypothetical: before taxes and trading costs.

About

Mirrors the disclosed stock holdings of Rep. E. Scott Rigell (Independent, VA) and family. It buys on the first trading day after each report is filed, sized by the middle of the value band reported, starts from the holdings listed in the member's annual disclosure report once that report is public, and holds each position until a sale is reported. Call options count as the stock until they expire. Members often report weeks or months late, so this is what a follower could actually have done.

E. Scott Rigell's trades →

Key statistics

MeasureStrategyS&P 500
Return a year (compound)+12.3%+13.8%
Total return+274%+334%
Last 12 months+22.6%+12.1%
Last 3 months+9.7%—
Last month+7.2%—
This year so far+19.6%—
Volatility a year15.0%16.7%
Sharpe ratio0.690.72
Biggest drop−27.7%−31.8%
Beta to the S&P 5000.771.00
Alpha a year (t-statistic)+1.2% (0.52)—
Share of weeks up60%—

Sharpe ratio uses returns above the 3-month Treasury bill rate. Alpha is the yearly return left after allowing for the strategy's exposure to the S&P 500 (CAPM); a t-statistic below about 2 means it cannot be told apart from luck. 51 reported trades were copied.

Insights

CompanyWeightHeld sinceReturn since
AAPL19.8%10 May 2016+1486.2%
MSFT11.9%29 Apr 2016+1083.7%
JNJ10.2%27 Dec 2016+203.2%
ABBV7.3%29 Apr 2016+624.4%
LOW7.1%29 Apr 2016+249.1%
XOM6.4%29 Apr 2016+220.6%
PG5.9%29 Apr 2016+173.0%
V5.5%26 Jan 2017+447.7%
JPM5.1%27 Dec 2016+408.3%
MRK4.9%17 Jun 2015+280.6%
MO4.7%29 Apr 2016+150.3%
PEP3.7%29 Apr 2016+88.7%
CVX3.5%29 Apr 2016+248.4%
GSK1.9%29 Apr 2016+86.3%
D1.5%29 Apr 2016+49.4%
GIS0.8%29 Apr 2016−15.6%
PeriodReturn a yearS&P 500SharpeS&P 500Biggest dropBetaAlpha (t)
Whole backtest17 Jun 2015 to 2 Nov 2026+12.3%+13.8%0.690.72−27.7%0.77+1.2% (0.52)
2018 onwards5 Jan 2018 to 2 Nov 2026+14.3%+13.9%0.760.66−27.7%0.76+2.9% (1.12)
Last three years3 Nov 2023 to 2 Nov 2026+18.3%+21.8%1.181.16−11.1%0.50+4.7% (0.96)
Last year7 Nov 2025 to 2 Nov 2026+24.3%+14.2%1.710.84−7.4%0.17+16.5% (1.55)
DateCompanyAction
26 Jan 2017VBought
27 Dec 2016JPMBought
27 Dec 2016JNJBought
27 Dec 2016BABought
10 May 2016AAPLBought
29 Apr 2016XOMBought
29 Apr 2016VZBought
29 Apr 2016SOBought
29 Apr 2016PGBought
29 Apr 2016PEPBought
29 Apr 2016MSFTBought
29 Apr 2016MOBought
29 Apr 2016LOWBought
29 Apr 2016GSKBought
29 Apr 2016GISBought
29 Apr 2016FBought
29 Apr 2016DBought
29 Apr 2016CVXBought
29 Apr 2016CCLBought
29 Apr 2016ABBVBought
19 Aug 2015GILDBought
21 Jul 2015AAPLBought
17 Jun 2015XOMBought
17 Jun 2015MRKBought
17 Jun 2015CMIBought

Dated on the first trading day after the report was filed, when a follower could have acted.

DateCompanyAction
26 Jan 2017BASold
31 Oct 2016VZSold
31 Oct 2016SOSold
29 Aug 2016FSold
30 Jun 2016CCLSold
29 Feb 2016XOMSold
29 Feb 2016GILDSold
29 Feb 2016CMISold
29 Feb 2016AAPLSold

Dated on the first trading day after the report was filed, when a follower could have acted.

Backtests are hypothetical and use today's listed companies only, which flatters results. Past performance does not predict future returns. This is research, not investment advice. How we backtest